Skip to content

â??A Clinical Study to check the Safety and efficacy of HSBP-121901 in babies"

â??An Open label, Clinical Study to Evaluate the Safety and efficacy of HSBP-121901 in babies of 0 â?? 36 months of age

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/06/043588
Enrollment
40
Registered
2022-06-29
Start date
Unknown
Completion date
Unknown
Last updated
2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Himalaya wellness company
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: . Babies in the age group between 0 to 36 months inclusive of both age and genders . Babies in general good health as determined from a recent medical history and the pediatrician. . Baby mother/legal representative preferably mother willing to give a voluntary written informed consent and agree to come for regular follow up. . Baby mother/legal representative, preferably mother willing to abide by and comply with the study protocol. . Babies should not participate in any other clinical study during participation in the current study. . Babies delivered after complete gestation ( > 38 weeks).

Exclusion criteria

Exclusion criteria: . Babies with a known history or present condition of allergic response to any other Diapers, toiletries or its components or ingredients as in the test product. . Babies with diarrhea/ bowel incontinence . Babies with diaper rashes or any allergies in the diaper area. . Any pre-existing systemic disease necessitating long term medications and other dermatological problems. . Babies requiring incubators/ ventilators or C-PAP. . Babies who have participated in a similar clinical investigation in the past four weeks.

Design outcomes

Primary

MeasureTime frame
. Mildness, Gentleness and irritation as assessed by Pediatrician Assessment Scoring. . Local intolerance of the product assessed by Pediatrician. . Helps to prevent diaper rash, less frequent change of diapers, Withstand multiple wettings, overnight use, Undisturbed, restful sleep for the baby; Less crying, less cranky after waking up, Provides soft and tender care with less friction of the diaper, No incidence of leakage of urine or faeces, Ease of diaper application and removal, overall satisfaction of the product by subjective questionnaire Timepoint: Day 1 and Day 8

Secondary

MeasureTime frame
To assess safety of product by reporting of all adverse events during the study period.Timepoint: Day 1 and Day 8

Countries

India

Contacts

Public ContactDr Soorya Narayan H

Himalaya wellness company

dr.swathi.b@himalayawellness.com9538969888

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026